Wang, M., Liu, A., Sun, Q., & Dong, W. (2025, January). Sintilimab for the treatment of lung adenocarcinoma-induced immune-related hypophysitis: A case report. Frontiers in Immunology.
Chicago Style (17th ed.) CitationWang, Ming-xing, Ai-xin Liu, Qing-ming Sun, and Wan-hui Dong. "Sintilimab for the Treatment of Lung Adenocarcinoma-induced Immune-related Hypophysitis: A Case Report." Frontiers in Immunology Jan. 2025.
MLA (9th ed.) CitationWang, Ming-xing, et al. "Sintilimab for the Treatment of Lung Adenocarcinoma-induced Immune-related Hypophysitis: A Case Report." Frontiers in Immunology, Jan. 2025.
Warning: These citations may not always be 100% accurate.
